4//SEC Filing
Driscoll Martin J 4
Accession 0001209191-19-026537
CIK 0001566373other
Filed
Apr 29, 8:00 PM ET
Accepted
Apr 30, 3:17 PM ET
Size
6.1 KB
Accession
0001209191-19-026537
Insider Transaction Report
Form 4
Driscoll Martin J
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2019-04-30$7.31/sh+5,000$36,550→ 65,400 total - Purchase
Common Stock
2019-04-30$7.36/sh+5,000$36,800→ 70,400 total
Documents
Issuer
Spring Bank Pharmaceuticals, Inc.
CIK 0001566373
Entity typeother
Related Parties
1- filerCIK 0001339402
Filing Metadata
- Form type
- 4
- Filed
- Apr 29, 8:00 PM ET
- Accepted
- Apr 30, 3:17 PM ET
- Size
- 6.1 KB